Active ingredient:
Ketorolac Tromethamine 30 mg.
Therapeutic indications:
Indicated for the short-term (5-days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a
postoperative setting.
Dosage form
Solution for I.M or I.V Injection.
